http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100373395-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-135 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-52 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-52 |
| filingDate | 2000-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100373395-B1 |
| titleOfInvention | Novel Thrombolytic Protein and a Process for Preparing the Same |
| abstract | The present invention is isolated from Enterococcus faecalis BRCA-5 (KFCC-11183), and provides a method for efficiently producing a tampa and electric protein that specifically acts on thrombotic proteins. According to the present invention, enterococcus faculis BRCA-5 is incubated in a temperature range of 25 ° C to 40 ° C under a condition of pH 5.0 to 9.0, thereby obtaining a temperase. It can be prepared, and the electric produced tampase not only has a strong thrombolytic activity, but also has no side effects such as toxicity or gastrointestinal disorders, and thus can be safely used as an active ingredient of an antithrombotic agent, as well as electric enterococcus faculis BRCA. -5 strain culture or tampa may be added to the health food. |
| priorityDate | 2000-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 513.